GSK-690693
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- GSK-690693
- DrugBank Accession Number
- DB12745
- Background
GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 425.4842
Monoisotopic: 425.217537765 - Chemical Formula
- C21H27N7O3
- Synonyms
- Not Available
- External IDs
- GSK 690693
- GSK690693
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as imidazo-[4,5-c]pyridines. These are organic heterocyclic compounds containing an imidazo-[4,5-c]pyridine ring system. Imidazo-[4,5-c]pyridine consists of an imidazole ring fused to a pyridine, so that the three ring nitrogen atoms are at the 1-, 2-, and 5-position, respectively.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Imidazopyridines
- Sub Class
- Imidazo-[4,5-c]pyridines
- Direct Parent
- Imidazo-[4,5-c]pyridines
- Alternative Parents
- Alkyl aryl ethers / Ynones / Pyridines and derivatives / Piperidines / N-substituted imidazoles / Imidolactams / Tertiary alcohols / Heteroaromatic compounds / Furazans / Dialkylamines show 4 more
- Substituents
- Alcohol / Alkyl aryl ether / Amine / Aromatic heteropolycyclic compound / Azacycle / Azole / Ether / Furazan / Heteroaromatic compound / Hydrocarbon derivative show 17 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- GWH480321B
- CAS number
- 937174-76-0
- InChI Key
- KGPGFQWBCSZGEL-ZDUSSCGKSA-N
- InChI
- InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1
- IUPAC Name
- 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-piperidin-3-yl]methoxy}-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
- SMILES
- [H][C@]1(COC2=C3N(CC)C(=NC3=C(N=C2)C#CC(C)(C)O)C2=NON=C2N)CCCNC1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 16725726
- PubChem Substance
- 347828935
- ChemSpider
- 20557532
- BindingDB
- 25013
- ChEBI
- 90677
- ChEMBL
- CHEMBL494089
- ZINC
- ZINC000034285211
- PDBe Ligand
- G93
- PDB Entries
- 3d0e / 5u94
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0664 mg/mL ALOGPS logP 2.25 ALOGPS logP 1.17 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 13.27 Chemaxon pKa (Strongest Basic) 10.07 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 8 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 137.14 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 125.04 m3·mol-1 Chemaxon Polarizability 46.04 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a6r-0000900000-276ca467f0e850fa5cbb Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0ab9-0104900000-ff77efd31f83bbc571ab Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0bt9-0005900000-1ee19dd30836755f900b Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-054p-5009200000-cf2226ad73f2c063556b Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-2019800000-d7240c761888758c54cb Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0002-0169100000-ca811647f5054f2e07e8 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 226.678514 predictedDarkChem Lite v0.1.0 [M-H]- 206.2075 predictedDeepCCS 1.0 (2019) [M+H]+ 226.627614 predictedDarkChem Lite v0.1.0 [M+H]+ 208.5655 predictedDeepCCS 1.0 (2019) [M+Na]+ 226.478514 predictedDarkChem Lite v0.1.0 [M+Na]+ 214.65866 predictedDeepCCS 1.0 (2019)
Drug created at October 21, 2016 00:00 / Updated at June 12, 2020 16:53